CBER Director Touts PDUFA Progress, Therapeutic Firsts in Fiscal 2017
The Center for Biologics Research and Evaluation met or exceeded its PDUFA goals in fiscal 2017, according to CBER Director Peter Marks. Source: Drug Industry Daily
The Center for Biologics Research and Evaluation met or exceeded its PDUFA goals in fiscal 2017, according to CBER Director Peter Marks. Source: Drug Industry Daily
The Department of Health and Human Services’ Office of Inspector General sent a letter to PhRMA seeking help in contributing to drug co-payments after a nonprofit ended its financial grants…
Drug pricing will be a key healthcare issue for 2018, with state pricing and transparency laws pushing pharma and life science companies to reconsider strategies and business models, according to…
Kala Pharma released mostly positive topline results from two Phase III clinical trials for KPI-121 in patients with dry eye disease. Source: BioSpace
Based in Cambridge, MA and founded in February 2016, Relay Therapeutics focuses on developing therapeutics based on protein motion. Source: BioSpace
Shares of TiGenix shot up more than 72 percent in pre-market trading after the deal was announced. Source: BioSpace
The company will undergo a reorganization that includes the termination of a number of sales representatives. Source: BioSpace
Board of Directors has initiated search to identify successor. Source: BioSpace
The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace
A look at why investors should stock up on Amgen, Celldex Therapeutics, and Novavax soon. Source: BioSpace